Literature DB >> 9254166

[Maximum static respiratory pressures in adults. The reference values for a Mediterranean Caucasian population].

P Morales1, J Sanchis, P J Cordero, J L Díez.   

Abstract

The aim of this study was to establish reference values for PImax and PEmax for the Mediterranean adult population. Male and female individuals between 18 and 83 years old meeting the criteria for consideration as references and residing in the metropolitan area of Valencia were assigned by decades to six subgroups, each containing at least 20 men and 20 women. PEmax was obtained from the point of maximum expiration (residual volume) and PImax was the point of maximum inspiration (total lung capacity). The cohort, which finally included 264 subjects (129 men and 135 women), was separated a priori by sex for data analysis. The following types of variables were studied: sociological (employment, educational level and exercise), biometric (age, height and weight) and spirometric results. A linear correlation analysis was performed for each pair of variables and a Kolmogorov-Smirnov test of normality was performed. In order to check the accuracy of PImax and PEmax readings, intra-individual variability was determined by performing three consecutive procedures over 3 days in 39 randomly selected individuals (18 men and 21 women). Significant inter-day and inter-test effects for respiratory pressures were thus ruled out. Predictive equations were worked out using a simple linear model including all predictive variables and eliminating weaker variables in a stepwise manner. Mathematical goodness of fit was assessed by a coefficient for multiple determinations (R2); also determined were the estimated standard error and statistical significance. We also compared observed and estimated values and the behavior of residual values in terms of their independence, normality and homoscedasticity. Reference limits were established by defining percentiles. The equations finally arrived at for men were as follows: PImax (-cmH2O) - 1.03 x Age + 0.59 x Weight + 133.07, PEmax (cmH2O) - 1.31 x Age + 263.12. The equations for women were PImax (-cmH2O) - 0.64 x Age + 125.18, PEmax (cmH2O) - 0.57 x Age + 0.65 x Weight + 116.26. Agreement with the usual references (the Black and Hyatt equations) was analyzed.

Entities:  

Mesh:

Year:  1997        PMID: 9254166     DOI: 10.1016/s0300-2896(15)30609-8

Source DB:  PubMed          Journal:  Arch Bronconeumol        ISSN: 0300-2896            Impact factor:   4.872


  10 in total

Review 1.  Clinical management of chronic obstructive pulmonary disease patients with muscle dysfunction.

Authors:  Joaquim Gea; Carme Casadevall; Sergi Pascual; Mauricio Orozco-Levi; Esther Barreiro
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

Review 2.  Nutritional status and muscle dysfunction in chronic respiratory diseases: stable phase versus acute exacerbations.

Authors:  Joaquim Gea; Antoni Sancho-Muñoz; Roberto Chalela
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

3.  How whole-body vibration can help our COPD patients. Physiological changes at different vibration frequencies.

Authors:  Eulogio Pleguezuelos; Paula Casarramona; Lluis Guirao; Beatriz Samitier; Pilar Ortega; Xavier Vila; Amin Del Carmen; Laura Ovejero; Eva Moreno; Noemi Serra; Manuel Gomís; Manuel V Garnacho-Castaño; Marc Miravitlles
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-10-18

4.  Longitudinal study of changes observed in quality of life, psychological state cognition and pulmonary and functional capacity after COVID-19 infection: A six- to seven-month prospective cohort.

Authors:  Tamara Del Corral; Noemí Menor-Rodríguez; Sara Fernández-Vega; Celia Díaz-Ramos; Sandra Aguilar-Zafra; Ibai López-de-Uralde-Villanueva
Journal:  J Clin Nurs       Date:  2022-05-09       Impact factor: 4.423

5.  Predictors and changes of physical activity in idiopathic pulmonary fibrosis.

Authors:  Diana Badenes-Bonet; Anna Rodó-Pin; Diego Castillo-Villegas; Vanesa Vicens-Zygmunt; Guadalupe Bermudo; Fernanda Hernández-González; Karina Portillo; Juana Martínez-Llorens; Roberto Chalela; Oswaldo Caguana; Jacobo Sellarés; Maria Molina-Molina; Xavier Duran; Joaquim Gea; Diego Agustín Rodríguez-Chiaradia; Eva Balcells
Journal:  BMC Pulm Med       Date:  2022-09-09       Impact factor: 3.320

6.  Comparison of post-COVID symptoms in patients with different severity profiles of the acute disease visited at a rehabilitation unit.

Authors:  Jean Claude Perrot; Macarena Segura; Marta Beranuy; Ignasi Gich; Mª Josepa Nadal; Alberto Pintor; Jimena Terra; Eliot Ramirez; Luis Daniel Paz; Helena Bascuñana; Vicente Plaza; Mª Rosa Güell-Rous
Journal:  PLoS One       Date:  2022-09-16       Impact factor: 3.752

7.  The FRAILMar Study Protocol: Frailty in Patients With Advanced Chronic Kidney Disease Awaiting Kidney Transplantation. A Randomized Clinical Trial of Multimodal Prehabilitation.

Authors:  María José Pérez-Sáez; Andrea Morgado-Pérez; Anna Faura; Elena Muñoz-Redondo; Miguel Gárriz; Maria Dolors Muns; Xavier Nogués; Ester Marco; Julio Pascual
Journal:  Front Med (Lausanne)       Date:  2021-05-19

8.  The Retornus-2 study: impact of respiratory muscle training in subacute stroke patients with dysphagia, study protocol of a double-blind randomized controlled trial.

Authors:  A Guillen-Sola; M Messaggi-Sartor; C Ramírez-Fuentes; E Marco; E Duarte
Journal:  Trials       Date:  2021-06-25       Impact factor: 2.279

9.  Systemic inflammation after inspiratory loading in chronic obstructive pulmonary disease.

Authors:  Antonia Fuster; Jaume Sauleda; Ernest Sala; Bernardí Barceló; Jaume Pons; Miguel Carrera; Aina Noguera; Bernat Togores; Alvar G N Agustí
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2008

10.  Normal values of the maximal respiratory pressures in healthy people older than 20 years old in the City of Manizales - Colombia.

Authors:  Lida Maritza Gil Obando; Alexandra López López; Carmen Liliana Avila
Journal:  Colomb Med (Cali)       Date:  2012-06-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.